ATAI also has VLS-01, which gives it a nearer-term Q4 2026 TRD catalyst. EMP-01 adds some optionality in social anxiety ...

The first venue built for a pro women’s sports team has been a game-changer for the NWSL’s second-most-valuable club, and ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today provides shareholders a ...

Oversubscribed $225 million concurrent private investment in public equity ("PIPE") with available cash to the combined ...

LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, adjunctive ...

The ambitious overhaul places uncrewed platforms at the center of future UK forces operations on land, at sea, and in the air ...

Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX) ("Biodexa” or the "Company”), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with ...

Explore the evolving landscape of male contraception, including novel nonhormonal pills and injectable hydrogels in clinical ...

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing ...

BingX Partners with Save the Children to Support Children at Risk in Western Balkans The new partnership will support migrant ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients ...

Advances strategic shift toward a disciplined research model prioritizing external innovation to accelerate rare disease pipeline growth- -Completes enrollment in Phase 3 ALPHA-ORBIT for navenibart ...